New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.Seminoma is a slow-growing form of testicular cancer that if untreated, typically met
World medicine November 25,2023
Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.Seminoma is a slow-growing form of testicular cancer that if untreated, typically met
World medicine November 25,2023
Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

New research in the March 2023 issue ofJNCCN-; Journal of the National Comprehensive Cancer Networkhighlights how the lack of genomic research for people with African ancestry, particularl
World medicine November 25,2023
Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

Study highlights poor clinical utility of germline testing in cancer patients of African ancestry

New research in the March 2023 issue ofJNCCN-; Journal of the National Comprehensive Cancer Networkhighlights how the lack of genomic research for people with African ancestry, particularl
World medicine November 25,2023
Facility-level disparities linked to racial health inequality among prostate cancer patients

Facility-level disparities linked to racial health inequality among prostate cancer patients

Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-lev
World medicine November 25,2023
Facility-level disparities linked to racial health inequality among prostate cancer patients

Facility-level disparities linked to racial health inequality among prostate cancer patients

Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-lev
World medicine November 25,2023
Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an ave
World medicine November 25,2023
Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an ave
World medicine November 25,2023
BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM1.0 in Slovakia, in collaboration with its local partner, Zentya. Zentya is a Slovak-based healthcare solution provider that is passio
World medicine November 25,2023
BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM1.0 in Slovakia, in collaboration with its local partner, Zentya. Zentya is a Slovak-based healthcare solution provider that is passio
World medicine November 25,2023
Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney,
World medicine November 25,2023
Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney,
World medicine November 25,2023
IU Cancer Center secures new, renewed ACS funding to support research and education programs

IU Cancer Center secures new, renewed ACS funding to support research and education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support researc
World medicine November 25,2023
IU Cancer Center secures new, renewed ACS funding to support research and education programs

IU Cancer Center secures new, renewed ACS funding to support research and education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support researc
World medicine November 25,2023
Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients sur
World medicine November 25,2023
Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients sur
World medicine November 25,2023
Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness, neuropsychiatric disability, or substance abuse are less likely to go for gynecological smear tests for cervical cancer and run more than twice the risk of developing the di
World medicine November 25,2023
Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness, neuropsychiatric disability, or substance abuse are less likely to go for gynecological smear tests for cervical cancer and run more than twice the risk of developing the di
World medicine November 25,2023
Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stres
World medicine November 25,2023
Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stres
World medicine November 25,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com